Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers - Concepedia

Concepedia

Publication | Closed Access

Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers

75

Citations

24

References

2014

Year

Ida Aronchik, B.A. Appleton, Stephen E. Basham, Kenneth Crawford, Mercedita Del Rosario, Laura V. Doyle, William F. Estacio, Jiong Lan, Mika Lindvall, Catherine A. Luu,

Molecular Cancer Research

Abstract

Two novel potent and selective RSK inhibitors will now allow a full assessment of the potential of RSK as a therapeutic target for oncology.

References

	Year	Citations

Page 1